Dermatology · San Angelo, TX
NPI
1003919994
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
120 E Beauregard Ave
San Angelo, TX, 76903
Phone (325) 658-1511
Groups this clinician bills Medicare through
Medicare paid, 2024
$236K
4,119 services
Medicare patients, 2024
1,183
Average age 75
Drug cost, 2024
$1.6M
1,272 prescriptions
Company payments, 2025
$984
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles E Greeson was code 99213 (office e&m - established), 929 times for 722 patients. In total Charles E Greeson billed 4,119 services in 77 codes, and Medicare paid $236K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 929 | 722 | $64.51 | $60K |
| 17003 Destruction Skin Lesion | Office | 733 | 280 | $4.32 | $3,168 |
| 17000 Destruction Skin Lesion | Office | 559 | 473 | $36.31 | $20K |
| 11102 Skin Biopsy | Office | 356 | 314 | $70.02 | $25K |
| 99212 Office E&M - Established | Office | 242 | 226 | $38.84 | $9,399 |
| 99214 Office E&M - Established | Office | 200 | 150 | $82.62 | $17K |
| 17110 Destruction Skin Lesion | Office | 126 | 121 | $76.13 | $9,592 |
| 11103 Skin Biopsy | Office | 121 | 87 | $39.57 | $4,789 |
| 99202 Office E&M - New | Office | 103 | 103 | $47.75 | $4,918 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 86 | 20 | $0.47 | $40.07 |
| 99203 Office E&M - New | Office | 85 | 85 | $77.77 | $6,610 |
| 12032 Wound Repair - All Levels | Office | 52 | 50 | $236.84 | $12K |
| 11642 Skin Lesion Excision | Office | 49 | 45 | $107.35 | $5,260 |
| 12052 Wound Repair - All Levels | Office | 41 | 38 | $238.02 | $9,759 |
| 11900 Skin | Office | 37 | 29 | $29.82 | $1,103 |
By year: 2022 $210K for 4,074 services; 2023 $213K for 3,900 services; 2024 $236K for 4,119 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 24 | 15 | $7.84 | $188 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles E Greeson prescribed most often to Medicare patients was Triamcinolone Acetonide, with 249 prescriptions and refills. In total Charles E Greeson wrote 1,272 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 249 | 270 | 177 | $2,043 |
| Ketoconazole Generic | 127 | 139 | 61 | $1,760 |
| Mometasone Furoate Generic | 125 | 130 | 76 | $2,611 |
| Doxycycline Hyclate Generic | 67 | 83 | 36 | $942 |
| Betamethasone Dipropionate Generic | 58 | 66 | 33 | $2,118 |
| Prednisone Generic | 48 | 56 | 29 | $144 |
| Dupixent Pen Dupilumab | 42 | 51 | Under 11 | $183K |
| Clobetasol Propionate Generic | 32 | 34 | 21 | $1,073 |
| Humira(Cf) Pen Adalimumab | 29 | 29 | Under 11 | $236K |
| Methotrexate Methotrexate Sodium | 29 | 46 | Under 11 | $475 |
| Cosentyx Unoready Pen Secukinumab | 26 | 26 | Under 11 | $216K |
| Doxepin Hcl Generic | 23 | 26 | Under 11 | $218 |
| Fluorouracil Generic | 22 | 23 | 18 | $1,420 |
| Fluconazole Generic | 21 | 42 | 17 | $379 |
| Tretinoin Generic | 21 | 23 | Under 11 | $1,207 |
Brand drugs: 221 claims; generic drugs: 1,051 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles E Greeson $984 ($984 in general payments such as food, travel and fees) from 14 companies. The largest payer was Galderma Laboratories, L.P. with $165.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 20 | $165 |
| Genzyme Corporation SNY | 3 | $158 |
| Janssen Biotech, Inc. JNJ | 9 | $148 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $135 |
| UCB, Inc. UCB.BR | 5 | $102 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $88.41 |
| Arcutis Biotherapeutics, Inc. ARQT | 4 | $61.91 |
| Krystal Biotech Inc KRYS | 1 | $23.68 |
| Kerecis Limited | 1 | $21.72 |
| Abbvie Inc. ABBV | 1 | $20.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.